The need to revisit VTE quality measures

JAMA

Volumn 312, Issue 3, 2014, Pages 286-287

  Kinnier, Christine V ^a,b   Barnard, Cindy ^a   Bilimoria, Karl Y ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ANTICOAGULATION; BLEEDING; CHEMOPROPHYLAXIS; COHORT ANALYSIS; DISEASE COURSE; ECHOGRAPHY; HEAD AND NECK CANCER; HEALTH CARE QUALITY; HOSPITAL CARE; HUMAN; INCIDENCE; LIFE THREAT; LUNG EMBOLISM; MORBIDITY; MORTALITY; NOTE; OBSERVATIONAL STUDY; PATIENT CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SURGICAL PATIENT; VENOUS THROMBOEMBOLISM;

EID: 84904269462     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.1841     Document Type: Note

References (9)

1. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published correction appears in Chest. 2012;142(6):1698]. Chest. 2012;141(2)(suppl):7S-47S.
2. Surgical care improvement project: VTE prophylaxis. National Quality Measures Clearinghouse. http://www.qualitymeasures.ahrq.gov/content.aspx?id= 46458. February 10, 2014.
3. Postoperative pulmonary embolism or DVT rates. National Quality Measures Clearinghouse. http://www.qualitymeasures.ahrq.gov/content.aspx?id= 38522&search=psi+12. Accessed February 10, 2014.
4. Clayburgh D, Stott W, Kochanowski T, et al. Prospective study of venous thromboembolism in patients with head and neck cancer after surgery: interim analysis. JAMA Otolaryngol Head Neck Surg. 2013;139(2):161-167.
5. Raslan AM, Fields JD, Bhardwaj A. Prophylaxis for venous thrombo-embolism in neurocritical care. Neurocrit Care. 2010;12(2):297-309.
6. Haut ER, Lau BD, Kraenzlin FS, et al. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma. Arch Surg. 2012;147(10):901-907.
7. Bilimoria KY, Chung J, Ju MH, et al. Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA. 2013;310(14):1482-1489.
8. Bergqvist D, Agnelli G, Cohen AT, et al; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346(13):975-980. (Pubitemid 34983247)
9. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001;135(10):858-869. (Pubitemid 33070682)